INCOME TAXES |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Income Tax Disclosure [Abstract] | |
| INCOME TAXES | INCOME TAXES The Company utilizes an estimated annual effective tax rate to determine its provision or benefit for income taxes for interim periods. The income tax provision or benefit is computed by multiplying the estimated annual effective tax rate by the year-to-date pre-tax book income (loss). For the nine months ended September 30, 2026, the income tax benefit was $46 compared to tax expense of $120 for the nine months ended September 30, 2025. Our effective income tax rate was 0.19% and (0.40)% for the nine months ended September 30, 2026 and 2025, respectively. The higher effective tax rate is primarily due to tax benefits on projected current Canadian losses, partially offset by other foreign discrete tax expenses compared to prior period. The deferred tax assets are offset by a valuation allowance at September 30, 2026, with the exception of certain deferred tax liabilities in Canada and in the UK. The Company has recorded tax benefit for income generated in Canada during the nine months ended September 30, 2026. Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the three-year period ended September 30, 2026. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth. The Company is currently under examination by the Internal Revenue Service for the year ended December 31, 2024. The Company was notified of this examination in the fourth quarter of 2026. The Company is in the early stages of evaluating the scope and potential impact of this examination.
|